II
ImmuNovus, Inc.
SEC filingOther Technology · Denton, NE
Amount raised$750Ksold at filing
Total offering$5M$4.3M still open
Investors in the raise2count reported to the SEC
FiledJul 29, 2026first sale Jul 16, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Tomas HelikarExecutive Officer
Executive officers, directors and promoters as listed on the Form D.